Motuporin

Kunitz Type Protease InhibitorRx: ResearchCompound: Research

Also known as: Motuporin

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Motuporin at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Motuporin is a marine‑sponge derived Kunitz‑type peptide that acts as a protease inhibitor and Kv1.3 channel blocker, investigated for immunomodulatory applications.

Mechanism of Action

Inhibits serine proteases (trypsin, chymotrypsin) and blocks Kv1.3 potassium channels, attenuating T‑cell activation

Routes of Administration

IntravenousSubcutaneous

Goals & Uses

  • ImmunosuppressionTherapeuticModerate

Contraindications

No contraindications recorded yet.

Adverse Effects

No adverse effects recorded yet.

Drug Interactions

No drug interactions recorded yet.

Population Constraints

No population constraints recorded yet.

Regulatory Status

  • United StatesUnapprovedInvestigational peptide, no regulatory approval

Evidence & Sources

No sources recorded yet.

Frequently Asked Questions

What is Motuporin?

Motuporin is a marine‑sponge derived Kunitz‑type peptide that acts as a protease inhibitor and Kv1.3 channel blocker, investigated for immunomodulatory applications.

What is Motuporin used for?

Motuporin is educationally associated with: Immunosuppression. Educational only — not medical advice.

How is Motuporin administered?

Recorded routes of administration: Intravenous, Subcutaneous.